{"title": "Analysis | What went wrong with coronavirus testing in the U.S.", "subtitle": "Missteps in rolling out the coronavirus testing infrastructure went unaddressed by leaders at the highest level of government, leaving the country blind to the virus's spread.", "author": "www.washingtonpost.com", "date": "2020-03-30T07:00:15.252Z", "vclaim_id": "vclaim-id-86341", "url": "https://www.washingtonpost.com/politics/2020/03/30/11-100000-what-went-wrong-with-coronavirus-testing-us/", "vclaim": "The CDC\u2019s decision to develop its own test is not unusual. \u201cThe CDC will develop their own test that is suited to an American health-care context and the regulations that exist here,\u201d Jeremy Konyndyk, a senior policy fellow at the Center for Global Development, explained. \u201cThat\u2019s how we normally would do things. A lot of countries don\u2019t have the capabilities that we have here. And so they need to rely on the WHO to provide tests to them. We don\u2019t have to do that in the United States.\u201d\n\nEven though the United States had cases in the single digits in late January, some public health officials were increasingly worried. Luciana Borio, the former head of medical and biodefense preparedness at the National Security Council, and Scott Gottlieb, who led the Food and Drug Administration (FDA) from May 2017 to April 2019, wrote a prescient op-ed in the Wall Street Journal, warning that if the virus is widespread, \u201cthe CDC will struggle to keep up with the volume of screening. Government should focus on working with private industry to develop easy-to-use, rapid diagnostic tests that can be made available to providers.\u201d Borio told NPR on Jan. 30: \u201cThe most important and effective way to control epidemics is to identify patients who are infected, exposed to the virus, and isolate them.\u201d", "lang": "en"}